Article PDF
Avoid common mistakes on your manuscript.
References
Spicknall KE, Mehregan DA. Necrobiotic xanthogranuloma. Int J Dermatol 2009; 48: 1–10.
Omarjee L, Janin A, Etienne G, et al. Necrobiotic xanthogranuloma: a paraneoplastic skin lesion of haematological malignancies?. Eur J Dermatol 2018; 28:384–6.
Fink C, Schneiderbauer R, Hartschuh W, et al. Necrobiotic xanthogranuloma associated with chronic lymphocytic leukemia. Int J Dermatol 2018; 57: 719–20.
Zahr ZA, Baer AN. Malignancy in myositis. Curr Rheumatol Rep 2011; 13: 208–15.
Findlay AR, Goyal NA, Mozaffar T. An overview of polymyositis and dermatomyositis. Muscle Nerve 2015; 51: 638–56.
Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study. Lancet 2001; 357: 96–100.
Casciola-Rosen L, Nagaraju K, Plotz P, et al. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 2005; 201: 591–601.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosure
Funding sources: none. Conflicts of interest: none.
About this article
Cite this article
Ramic, L., Steiner, A., Breier, F. et al. Necrobiotic xanthogranuloma and polymyositis in a patient with squamous cell lung cancer: a new paraneoplastic entity?. Eur J Dermatol 30, 746–747 (2020). https://doi.org/10.1684/ejd.2020.3913
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2020.3913